Nikolaus Rajewsky|Geneviève Almouzni|Stanislaw A. Gorski|Stein Aerts|Ido Amit|Michela G. Bertero|Christoph Bock|Annelien L. Bredenoord|Giacomo Cavalli|Susanna Chiocca|Hans Clevers|Bart De Strooper|Angelika Eggert|Jan Ellenberg|Xosé M. Fernández|Marek Figlerowicz|Thomas Gasser|Norbert Hübner|Jørgen Kjems|Juergen A. Knoblich|Grietje Krabbe|Peter Lichter|Sten Linnarsson|Jean?Christophe Marine|John C. Marioni|Marc A. Mart??-Renom|Mihai G. Netea|Dörthe Nickel|Marcelo Nöllmann|Halina R. Novak|Helen Parkinson|Stefano Piccolo|Inês Pinheiro|Ana Pombo|Christian Popp|Wolf Reik|Sergio Roman?Roman|Philip Rosenstiel|Joachim L. Schultze|Oliver Stegle|Amos Tanay|Giuseppe Testa|Dimitris Thanos|Fabian J. Theis|Maria?Elena Torres?Padilla|Alfonso Valencia|Céline Vallot|Alexander van Oudenaarden|Marie Vidal|Thierry Voet
LifeTime and improving European healthcare through cell-based interceptive medicine
Institute Curie|Dynamique du noyau|Institute Curie
describe lifetime initiative aims track understand target human cells onset progression complex diseases analyse response therapy singlecell resolution mission implemented development integration application singlecell multiomics imaging artificial intelligence patientderived experimental disease models progression health disease analysis large molecular clinical datasets identify molecular mechanisms create predictive computational models disease progression reveal new drug targets therapies timely detection interception disease embedded ethical patientcentred vision achieved interactions across academia hospitals patient associations health data management systems industry application strategy key medical challenges cancer neurological neuropsychiatric disorders infectious chronic inflammatory cardiovascular diseases singlecell level usher cellbased interceptive medicine europe next decade